HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sagar Lonial Selected Research

Dexamethasone (Maxidex)

6/2022Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial.
1/2022Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
11/2021Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a study.
10/2021Daratumumab Plus Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma.
1/2021Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.
1/2021Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study.
1/2021Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR.
1/2021Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.
12/2020Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma.
10/2020Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sagar Lonial Research Topics

Disease

197Multiple Myeloma
06/2022 - 01/2003
66Neoplasms (Cancer)
10/2022 - 01/2004
16Peripheral Nervous System Diseases (PNS Diseases)
03/2017 - 01/2006
14Thrombocytopenia (Thrombopenia)
01/2020 - 12/2005
13Lymphoma (Lymphomas)
01/2016 - 12/2004
12Fatigue
12/2020 - 08/2010
10Disease Progression
01/2022 - 06/2005
10Neutropenia
01/2020 - 11/2007
9Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2015 - 10/2006
8Hematologic Neoplasms (Hematological Malignancy)
06/2014 - 02/2002
7Infections
02/2022 - 02/2002
6Residual Neoplasm
10/2021 - 01/2003
6Diarrhea
01/2020 - 10/2013
5Graft vs Host Disease (Graft-Versus-Host Disease)
10/2008 - 07/2003
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 04/2009
4Chromosome Aberrations (Chromosome Abnormalities)
12/2018 - 09/2015
4Melanoma (Melanoma, Malignant)
01/2018 - 01/2004
4Renal Insufficiency (Renal Failure)
01/2018 - 03/2007
4Leukemia
01/2016 - 10/2003
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2015 - 10/2006
3Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2021 - 06/2008
3Nausea
01/2020 - 08/2014
3Myocarditis (Carditis)
09/2019 - 01/2018
3Sepsis (Septicemia)
09/2019 - 01/2017
3Castleman Disease (Castleman's Disease)
01/2016 - 08/2010
3Lung Neoplasms (Lung Cancer)
07/2007 - 05/2007
2Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2021 - 01/2019
2Pain (Aches)
12/2020 - 06/2014
2Smoldering Multiple Myeloma
10/2020 - 12/2013

Drug/Important Bio-Agent (IBA)

64Bortezomib (Velcade)FDA Link
01/2022 - 06/2005
54Dexamethasone (Maxidex)FDA LinkGeneric
06/2022 - 06/2005
41Lenalidomide (CC 5013)FDA Link
06/2022 - 10/2007
30Proteasome InhibitorsIBA
11/2021 - 12/2005
22daratumumabIBA
01/2022 - 01/2016
22Monoclonal AntibodiesIBA
01/2022 - 01/2006
18Pharmaceutical PreparationsIBA
10/2021 - 02/2002
16Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2007
16Proteasome Endopeptidase Complex (Proteasome)IBA
12/2020 - 04/2006
14carfilzomibIBA
10/2021 - 06/2011
14PanobinostatIBA
01/2021 - 05/2012
10elotuzumabIBA
06/2022 - 06/2012
10Thalidomide (Thalomid)FDA Link
09/2014 - 05/2006
9Immunomodulating AgentsIBA
11/2021 - 06/2009
9ixazomibIBA
01/2021 - 08/2014
8Melphalan (Alkeran)FDA LinkGeneric
01/2022 - 05/2010
7Immunoglobulins (Immunoglobulin)IBA
02/2022 - 04/2011
7belantamab mafodotinIBA
11/2021 - 01/2020
7pomalidomideIBA
11/2021 - 03/2014
7Immunoconjugates (Immunoconjugate)IBA
11/2021 - 01/2019
7Cisplatin (Platino)FDA LinkGeneric
01/2020 - 10/2006
7EnzymesIBA
01/2019 - 12/2011
7CytokinesIBA
01/2019 - 01/2004
7Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2015 - 12/2004
6Prednisone (Sone)FDA LinkGeneric
01/2018 - 09/2007
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2015 - 09/2007
6Rituximab (Mabthera)FDA Link
11/2015 - 09/2007
6Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2015 - 12/2002
5VaccinesIBA
10/2022 - 03/2008
5Biomarkers (Surrogate Marker)IBA
10/2021 - 09/2013
5selinexorIBA
01/2021 - 01/2019
5Vincristine (Oncovin)FDA LinkGeneric
11/2015 - 10/2006
4AntibodiesIBA
01/2022 - 12/2002
4venetoclaxIBA
01/2021 - 01/2019
4Histone Deacetylase InhibitorsIBA
12/2020 - 05/2012
4Phosphotransferases (Kinase)IBA
01/2020 - 12/2011
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2019 - 07/2007
4Doxorubicin (Adriamycin)FDA LinkGeneric
11/2015 - 09/2007
4plerixaforFDA Link
10/2015 - 10/2011
3Chimeric Antigen ReceptorsIBA
01/2021 - 01/2019
3B-Cell Maturation AntigenIBA
01/2021 - 01/2020
3RNA (Ribonucleic Acid)IBA
01/2021 - 11/2015
3EverolimusFDA Link
10/2020 - 01/2019
3PlatinumIBA
01/2020 - 01/2018
3AntigensIBA
01/2017 - 12/2002
3Histone Deacetylases (Histone Deacetylase)IBA
01/2017 - 09/2010
3acetoacetic acid (acetoacetate)IBA
01/2017 - 08/2015
3Epidermal Growth Factor (EGF)IBA
12/2016 - 02/2014
3siltuximabIBA
01/2016 - 08/2010
3fludarabineIBA
09/2015 - 10/2003
3liposomal doxorubicin (Doxil)FDA Link
09/2014 - 05/2010
3Etoposide (VP 16)FDA LinkGeneric
06/2014 - 10/2006
3Cytarabine (Cytosar-U)FDA LinkGeneric
12/2013 - 10/2006
3Tyrosine (L-Tyrosine)FDA Link
12/2011 - 11/2009
2indatuximab ravtansineIBA
11/2021 - 01/2019
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2021 - 01/2019
2VorinostatFDA Link
12/2020 - 10/2013

Therapy/Procedure

105Therapeutics
02/2022 - 01/2003
14Stem Cell Transplantation
06/2022 - 08/2009
14Transplantation
06/2022 - 02/2002
13Drug Therapy (Chemotherapy)
01/2019 - 12/2004
8Immunotherapy
09/2021 - 01/2003
5Cell Transplantation
12/2015 - 08/2011
4Hematopoietic Stem Cell Transplantation
01/2016 - 03/2014
4Blood Component Removal (Apheresis)
10/2015 - 12/2004
4Hematopoietic Stem Cell Mobilization
09/2013 - 10/2006
3Salvage Therapy
12/2020 - 10/2006
3Radiotherapy
12/2020 - 01/2016
3Autologous Transplantation
04/2015 - 10/2006
2Precision Medicine
01/2022 - 01/2016
2Intravenous Infusions
01/2020 - 01/2017